Basket cover image
15 handpicked stocks

Political Donors: Team Red

This collection showcases companies with significant financial ties to the Republican party. These carefully selected stocks, primarily from energy and industrial sectors, may benefit from favorable legislation if their supported political agenda succeeds.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at June 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

XOM

Exxon Mobil Corp.

XOM

Current price

$107.42

As a global energy giant, its interests in oil and gas exploration are closely aligned with Republican energy policies.

CVX

Chevron Corporation

CVX

Current price

$152.00

This major integrated oil company historically benefits from Republican-led initiatives that favor fossil fuel production.

COP

ConocoPhillips

COP

Current price

$93.76

A leading exploration and production company, its focus on domestic energy resources aligns with traditional Republican platforms.

About This Group of Stocks

1

Our Expert Thinking

These companies share a history of supporting Republican candidates and causes through corporate donations and PACs. Their business interests often align with Republican policy priorities like deregulation, reduced corporate taxes, and energy independence.

2

What You Need to Know

This collection focuses heavily on energy and industrial stocks, particularly in oil, gas, and manufacturing. These sectors tend to be cyclical and may perform differently based on which political party controls government policy and regulation.

3

Why These Stocks

Each company was selected based on public records of political contributions and their alignment with Republican policy goals. They represent established firms whose business operations could benefit from Republican-led initiatives, especially during election cycles.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+28.35%

Group Performance Snapshot

28.35%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 28.35% over the next year.

11 of 15

Stocks Rated Buy by Analysts

11 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🗳️

Election Cycle Opportunity

As election season approaches, these companies could benefit from increased visibility and potential policy shifts favoring their industries. Political momentum often creates market movement.

Energy Policy Winners

Many of these stocks are positioned in fossil fuel and energy infrastructure sectors that historically benefit from Republican-led regulatory changes and energy independence initiatives.

📊

Political Alignment Strategy

By understanding which companies support specific political agendas, you gain insight into potential beneficiaries of future policy shifts. This could be particularly valuable during political transitions.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.